Skip to main content
Log in

Amphotericin B und Flucytosin-Therapie beiAspergillus-Pneumonie und akutem Nierenversagen

Amphotericin B and flucytosine therapy in Aspergillus pneumonia and acute kidney failure

Doppelinfektion mitA. flavus undA. fumigatus

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Kidney failure and pneumonia byAspergillus flavus andA. fumigatus were found in a 56-year-old woman who had received antibiotic and corticoid treatment to control high fever. Her bloody tracheal secretion was a suspension of granule-like spore-free colonies of bothAspergillus species. Hemorrhages in mucous membranes and skin suggested a hematogenous dissemination of the fungi. Aspergillus spores in the soil of ornamental plants were assumed to be responsible for the inhalatory infection. The kidney function normalized rapidly under treatment by amphotericin B plus flucytosine and hemodialysis performed eight times. After 29 days of antimycotic treatment (amphotericin B 463 mg, flucytosine 150 g), besides normalization of the kidney function, healing of the penumonia and bleeding from skin and mucal membranes took place. One and a half years later kidney function and blood parameters were found to be normal. In cases ofAspergillus pneumonia and kidney failure, a combined treatment by hemodialysis and amphotericin B plus flucytosine is recommended. In addition, there is discussion of the general importance of uremia and its influence on the mycotic infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

5-FC:

Flucytosin (Ancotil-Roche®)

Literatur

  1. Block EE, Bennett JE, Livoti KG, Klein WJ, MacGregor RR, Henderson L (1974) Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Ann Intern Med 80:613–617

    PubMed  Google Scholar 

  2. Essers L, Hantschke D, Leisse KH (1982) Serumspiegelüberwachung von 5-Fluorcytosin durch Hochleistungsflüssigkeits-Chromatographie. Mykosen 25:183–188

    PubMed  Google Scholar 

  3. Fromtling RA, Fromtling AM, Staib F, Müller S (1981) Effect of uremia on lymphocyte transformation and chemiluminescence by spleen cells of normal and Cryptoccus neoformans infected mice. Infect Immun 32:1073–1078

    PubMed  Google Scholar 

  4. Fromtling RA, Abruzzo GK (1985) Chemiluminescence as a tool for the evaluation of antimicrobial agents: A review. Meth and Find Exptl Clin Pharmacol 7:493–500

    Google Scholar 

  5. Grosse G, l'Age M, Staib F (1985) Perakute disseminiert verlaufene, tödliche Aspergillus fumigatus-Infektion bei Leberversagen und Kortikoidtherapie. Klin Wochenschr 63:523–528

    PubMed  Google Scholar 

  6. Heidemann H, Kirch W, Gerkens J, Branch R (1983) Salzbeladung verringert Amphotericin B-induzierte Nephrotoxizität. Verh Dtsch Ges Innere Med Bd. 89. Bergmann, München

    Google Scholar 

  7. Henze G, Aldenhoff P, Stephani U, Grosse G, Kazner E, Staib F (1982) Successful treatment of pulmonary and cerebral aspergillosis in an immunosuppressed child. Eur J Pediatr 138:263–265

    PubMed  Google Scholar 

  8. Kaspar RL, Drutz DJ (1975) Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B. Antimicrob Agents Chemother 7:462–465

    PubMed  Google Scholar 

  9. Minguillon C, Friedmann W, Vogel M, Stoltenburg-Didinger G, Staib F (1984) Zum Verteilungsmuster entzündlicher Veränderungen bei Infektionen mit Aspergillus flavus nach zytostatischer Therapie. Verh Dtsch Ges Path 68:568

    Google Scholar 

  10. Raper KB, Fennell DI (1977) The genus Aspergillus. RE Krieger, Huntington New York

    Google Scholar 

  11. Scholer HJ (1983) Chemotherapie der Aspergillenkrankheiten der Lunge. Mykosen 26:173–196

    PubMed  Google Scholar 

  12. Staib F (1964) Das Serum-Reststickstoff-Auxanogramm (mit Sproß- und Schimmelpilzen). Zbl Bakt I. Orig 194:379–406

    Google Scholar 

  13. Staib F (1967) Zum Verhalten von Cryptococcus neoformans gegenüber Serumfraktionen. In: Heite HJ (Hrsg): Krankheiten durch Aktinomyzeten und verwandte Erreger. Wechselwirkungen zwischen pathogenen Pilzen und Wirtsorganismus. Springer, Berlin Heidelberg New York. S. 87

    Google Scholar 

  14. Staib F (1985) Pleural fluid as nutrient substratum for Aspergillus fumigatus and A. flavus. Submerged growth in pleural fluid and extracellular proteolysis in pleural fluid agar. Zbl Bakt Hyg. A 260:543–549

    Google Scholar 

  15. Staib F (1985) Vorschläge zur Bekämpfung aerogener tiefer Mykosen bei immungeschwächten Personen. Bundesgesundheitsblatt 28:132–138

    Google Scholar 

  16. Staib F, Bohl D, Foth B, Mishra SK, Rajendran C, Müller JA (1980) Tödliche Aspergillose nach Infarktpneumonie. Prax Klin Pneumol 34:732–738

    PubMed  Google Scholar 

  17. Wegmann T (1986) Medizinische Mykologie — ein praktischer Leitfaden. Edition Roche, Basel. 3. Auflage

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Staib, F., Bennhold, I., Voigt, H.W. et al. Amphotericin B und Flucytosin-Therapie beiAspergillus-Pneumonie und akutem Nierenversagen. Klin Wochenschr 65, 40–47 (1987). https://doi.org/10.1007/BF01785527

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01785527

Key words

Navigation